Resultados globales: 14 registros encontrados en 0.04 segundos.
Artículos, Encontrados 10 registros
Documentos de investigación, Encontrados 4 registros
Artículos Encontrados 10 registros  
1.
9 p, 369.1 KB Kidney transplantation and COVID-19 renal and patient prognosis / Toapanta, Néstor (Universitat Autònoma de Barcelona. Departament de Medicina) ; Torres, Irina B (Universitat Autònoma de Barcelona. Departament de Medicina) ; Sellarés, Joana (Universitat Autònoma de Barcelona. Departament de Medicina) ; Chamoun, Betty (Universitat Autònoma de Barcelona. Departament de Medicina) ; Serón, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina)
Coronavirus disease 2019 (COVD-19) emerged as a pandemic in December 2019. Infection has spread quickly and renal transplant recipients receiving chronic immunosuppression have been considered a population at high risk of infection, complications and infection-related death. [...]
2021 - 10.1093/ckj/sfab030
Clinical Kidney Journal, Vol. 14 (march 2021) , p. i21-i29  
2.
10 p, 625.3 KB Challenges in primary focal segmental glomerulosclerosis diagnosis : from the diagnostic algorithm to novel biomarkers / Jacobs-Cachá, Conxita (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vergara, Ander (Hospital Universitari Vall d'Hebron) ; García-Carro, Clara (Red de Investigación Renal) ; Agraz Pamplona, Irene (Red de Investigación Renal) ; Toapanta-Gaibor, Nestor (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ariceta, Gema (Hospital Universitari Vall d'Hebron) ; Moreso, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Serón, Daniel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; López-Hellín, Joan (Hospital Universitari Vall d'Hebron) ; Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Primary or idiopathic focal segmental glomerulosclerosis (FSGS) is a kidney entity that involves the podocytes, leading to heavy proteinuria and in many cases progresses to end-stage renal disease. Idiopathic FSGS has a bad prognosis, as it involves young individuals who, in a considerably high proportion (∼15%), are resistant to corticosteroids and other immunosuppressive treatments as well. [...]
2020 - 10.1093/ckj/sfaa110
Clinical Kidney Journal, Vol. 14 (august 2020) , p. 482-491  
3.
14 p, 558.9 KB The Banff 2019 Kidney Meeting Report (I) : Updates on and clarification of criteria for T cell- and antibody-mediated rejection / Loupy, Alexandre (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Haas, Mark (Cedars-Sinai Medical Center) ; Roufosse, Candice (Imperial College London and North West London Pathology) ; Naesens, Maarten (University Hospitals Leuven) ; Adam, Benjamin (University of Alberta) ; Afrouzian, Marjan (University of Texas Medical Branch) ; Akalin, Enver (Montefiore Medical Center) ; Alachkar, Nada (Johns Hopkins University School of Medicine) ; Bagnasco, Serena (Johns Hopkins University School of Medicine) ; Becker, Jan U. (Uniklinik Köln (Colònia, Alemanya)) ; Cornell, Lynn D. (Mayo Clinic) ; Clahsen-van Groningen, Marian C. (Erasmus MC) ; Demetris, Anthony J. (University of Pittsburgh. University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Dragun, Duska (Charite Universitätsmedizin. Berlin Institute of Health) ; Duong van Huyen, Jean-Paul (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Farris, Alton B. (Emory University) ; Fogo, Agnes B. (Vanderbilt University) ; Gibson, Ian W. (University of Manitoba) ; Glotz, Denis (INSERM U 1160. Université Paris VII. Hopital Saint Louis) ; Gueguen, Juliette (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Kikic, Zeljko (Medical University of Vienna) ; Kozakowski, Nicolas (Medical University of Vienna) ; Kraus, Edward (Johns Hopkins University School of Medicine) ; Lefaucheur, Carmen (INSERM U 1160. Université Paris VII. Hopital Saint Louis) ; Liapis, Helen (Washington University School of Medicine) ; Mannon, Roslyn B. (University of Alabama School of Medicine) ; Montgomery, Robert A. (NYU Langone Transplant Institute) ; Nankivell, Brian J. (Westmead Hospital) ; Nickeleit, Volker (The University of North Carolina) ; Nickerson, Peter (University of Manitoba) ; Rabant, Marion (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Racusen, Lorraine (Johns Hopkins University School of Medicine) ; Randhawa, Parmjeet (University of Pittsburgh. University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Robin, Blaise (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Rosales, Ivy A. (Harvard Medical School) ; Sapir-Pichhadze, Ruth (McGill University) ; Schinstock, Carrie A. (Mayo Clinic) ; Seron, Daniel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Singh, Harsharan K. (The University of North Carolina) ; Smith, Rex N. (Harvard Medical School) ; Stegall, Mark D. (Mayo Clinic) ; Zeevi, Adriana (University of Pittsburgh. University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Solez, Kim (University of Alberta) ; Colvin, Robert B. (Harvard Medical School) ; Mengel, Michael (University of Alberta) ; Universitat Autònoma de Barcelona
The XV. Banff conference for allograft pathology was held in conjunction with the annual meeting of the American Society for Histocompatibility and Immunogenetics in Pittsburgh, PA (USA) and focused on refining recent updates to the classification, advances from the Banff working groups, and standardization of molecular diagnostics. [...]
2020 - 10.1111/ajt.15898
American Journal of Transplantation, Vol. 20 (may 2020) , p. 2318-2331  
4.
12 p, 537.1 KB Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation : The 2019 Expert Consensus From the Transplantion Society Working Group / Schinstock, Carrie A. (Mayo Clinic William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN) ; Mannon, Roslyn B. (Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL) ; Budde, Klemens (Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany) ; Chong, Anita S. (Section of Transplantation, Department of Surgery, The University of Chicago, Chicago, IL) ; Haas, Mark (Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA) ; Knechtle, Stuart (Duke Transplant Center, Department of Surgery, Duke University School of Medicine, Durham, NC) ; Lefaucheur, Carmen (Université de Paris, Department of Transplantation, Saint Louis Hospital, Paris, France) ; Montgomery, Robert A. (NYU Langone Transplant Institute) ; Nickerson, Peter (Transplant Immunology Laboratory, Shared Health and Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada) ; Tullius, Stefan G. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Ahn, Curie (Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea) ; Askar, Medhat (Baylor University Medical Center, Transplant Immunology, Dallas, TX) ; Crespo, Marta (Institut Hospital del Mar d'Investigacions Mèdiques) ; Chadban, Steven J. (Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia) ; Feng, Sandy (Department of Surgery, University of California San Francisco, San Francisco, CA) ; Jordan, Stanley C. (Comprehensive Transplant Center, Cedars-Sinai Medical Center, West Hollywood, CA) ; Man, Kwan (Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China) ; Mengel, Michael (Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada) ; Morris, Randall E. (Stanford University School of Medicine, Stanford, CA) ; O'Doherty, Inish (Critical Path Institute, Tucson, AZ) ; Ozdemir, Binnaz H. (Department of Pathology, Baskent University, School of Medicine, Ankara, Turkey) ; Seron, Daniel (Hospital Universitari Vall d'Hebron) ; Tambur, Anat R. (Comprehensive Transplant Center, Northwestern University, Chicago, IL) ; Tanabe, Kazunari (Department of Urology, Tokyo Women's Medical University, Tokyo, Japan) ; Taupin, Jean-Luc (INSERM U976 Institut de Recherche Saint-Louis, Université Paris Diderot, Paris, France) ; O'Connell, Philip J. (Centre for Transplant and Renal Research, Westmead Institute of Medical Research, University of Sydney and Renal Unit, Westmead Hospital, NSW, Australia) ; Universitat Autònoma de Barcelona
With the development of modern solid-phase assays to detect anti-HLA antibodies and a more precise histological classification, the diagnosis of antibody-mediated rejection (AMR) has become more common and is a major cause of kidney graft loss. [...]
2020 - 10.1097/TP.0000000000003095
Transplantation, Vol. 104 (april 2020) , p. 911-922  
5.
11 p, 320.0 KB Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease : Baseline results of the PRECISED study / Simó, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bañeras, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández Pascual, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez-Palomares, José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Valente, Filipa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gutierrez, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; González-Alujas, Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ferreira, Ignacio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Aguadé-Bruix, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Seron, Daniel (Red de Investigación Renal) ; Genescà, Joan (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Boixadera, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García-Arumí, José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Planas, Alejandra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó-Servat, Olga (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Objective Detection of subclinical cardiovascular disease (CVD) has significant impact on the management of type 2 diabetes. We examined whether the assessment of diabetic retinopathy (DR) is useful for identifying patients at a higher risk of having silent CVD. [...]
2019 - 10.1136/bmjdrc-2019-000845
BMJ open diabetes research and care, Vol. 7 Núm. 1 (29 2019) , p. e000845  
6.
12 p, 571.6 KB Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus / Torres, Armando (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Hernández, Domingo (Instituto de Investigación Biomédica de Málaga (IBIMA)) ; Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina) ; Serón, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Burgos, María Dolores (Instituto de Investigación Biomédica de Málaga (IBIMA)) ; Pallardó, Luis M. (Hospital Universitario Dr Peset, Valencia, Spain) ; Kanter, Julia (Hospital Universitario Dr Peset, Valencia, Spain) ; Díaz Corte, Carmen (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Rodríguez, Minerva (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Díaz Gómez, Joan Manuel (Institut d'Investigació Biomèdica Sant Pau) ; Silva, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Valdes, Francisco (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Fernández-Rivera, Constantino (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Osuna, Antonio (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gracia Guindo, María C. (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gómez Alamillo, Carlos (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Ruiz, Juan C. (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Marrero Miranda, Domingo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Pérez-Tamajón, Lourdes (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Rodríguez, Aurelio (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; González-Rinne, Ana (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Alvarez, Alejandra (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Perez-Carreño, Estefanía (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; de la Vega Prieto, María José (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Henriquez, Fernando (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Gallego Samper, Roberto (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Salido, Eduardo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Porrini, Esteban (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Universitat Autònoma de Barcelona
Despite the high incidence of posttransplant diabetes mellitus (PTDM) among high-risk recipients, no studies have investigated its prevention by immunosuppression optimization. We conducted an open-label, multicenter, randomized trial testing whether a tacrolimus-based immunosuppression and rapid steroid withdrawal (SW) within 1 week (Tac-SW) or cyclosporine A (CsA) with steroid minimization (SM) (CsA-SM), decreased the incidence of PTDM compared with tacrolimus with SM (Tac-SM). [...]
2018 - 10.1016/j.ekir.2018.07.009
Kidney International Reports, Vol. 3 (july 2018) , p. 1304-1315  
7.
15 p, 1.1 MB The Banff 2017 Kidney Meeting Report : Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials / Haas, M. (Cedars-Sinai Medical Center) ; Loupy, A. (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Lefaucheur, C. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Roufosse, C. (Imperial College London and North West London Pathology) ; Glotz, D. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ; Nankivell, B. J. (Westmead Hospital) ; Halloran, P. F. (University of Alberta) ; Colvin, R. B. (Harvard Medical School) ; Akalin, Enver (Montefiore Medical Center) ; Alachkar, N. (Johns Hopkins University School of Medicine) ; Bagnasco, S. (Johns Hopkins University School of Medicine) ; Bouatou, Y. (Geneva University Hospitals) ; Becker, J. U. (Uniklinik Köln (Colònia, Alemanya)) ; Cornell, L. D. (Mayo Clinic) ; van Huyen, J. P. Duong (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Gibson, I. W. (University of Manitoba) ; Kraus, Edward S. (Johns Hopkins University) ; Mannon, R. B. (University of Alabama School of Medicine) ; Naesens, M. (University Hospitals Leuven. University of Leuven & Department of Nephrology) ; Nickeleit, V. (The University of North Carolina School of Medicine) ; Nickerson, P. (University of Manitoba) ; Segev, D. L. (Johns Hopkins Medical Institutions) ; Singh, H. K. (The University of North Carolina School of Medicine) ; Stegall, M. (Mayo Clinic) ; Randhawa, P. (University of Pittsburgh) ; Racusen, L. (Johns Hopkins University School of Medicine) ; Solez, K. (University of Alberta) ; Mengel, M. (University of Alberta) ; Universitat Autònoma de Barcelona
The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications of inflammation in areas of interstitial fibrosis and tubular atrophy (i-) and its relationship to T cell-mediated rejection (), and the continued evolution of molecular diagnostics, particularly in the diagnosis of antibody-mediated rejection (). [...]
2018 - 10.1111/ajt.14625
American Journal of Transplantation, Vol. 18, Issue 2 (February 2018) , p. 293-307  
8.
14 p, 167.5 KB The Banff 2015 Kidney Meeting Report : Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology / Loupy, A. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Haas, M. (Cedars-Sinai Medical Center) ; Solez, K. (University of Alberta) ; Racusen, L. (Johns Hopkins University School of Medicine) ; Glotz, D. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ; Nankivell, B. J. (Westmead Hospital) ; Colvin, R. B. (Harvard Medical School) ; Afrouzian, Marjan (University of Texas Medical Branch) ; Akalin, Enver (Albert Einstein College of Medicine) ; Alachkar, N. (Johns Hopkins University School of Medicine) ; Bagnasco, S. (Johns Hopkins University School of Medicine) ; Becker, J. U. (Uniklinik Köln (Colònia, Alemanya)) ; Cornell, L. (Mayo Clinic) ; Drachenberg, C. (University of Maryland School of Medicine) ; Dragun, D. (Charité Universitätsmedizin) ; de Kort, H. (Leiden University Medical Center) ; Gibson, I. W. (University of Manitoba) ; Kraus, E. S. (Johns Hopkins University School of Medicine) ; Lefaucheur, C. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Legendre, C. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Liapis, H. (Washington University) ; Muthukumar, T. (New York Presbyterian Hospital-Weill Cornell Medicine) ; Nickeleit, V. (University of North Carolina) ; Orandi, B. (Johns Hopkins University School of Medicine) ; Park, W. (Mayo Clinic) ; Rabant, M. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Randhawa, P. (University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Reed, E. F. (University of California) ; Roufosse, C. (Hammersmith Hospital) ; Seshan, S. V. (Weill Cornell Medicine) ; Sis, B. (University of Alberta) ; Singh, H. K. (University of North Carolina) ; Schinstock, C. (Mayo Clinic) ; Tambur, A. (Northwestern University. Transplant Immunology Laboratory) ; Zeevi, A. (University of Pittsburgh Medical Center) ; Mengel, M. (University of Alberta) ; Universitat Autònoma de Barcelona
The Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody-mediated rejection () from the 2013 meeting, reports from active Banff Working Groups, the relationships of donor-specific antibody tests (anti- and non-) with transplant histopathology, and questions of molecular transplant diagnostics. [...]
2017 - 10.1111/ajt.14107
American Journal of Transplantation, Vol. 17, Issue 1 (January 2017) , p. 28-41  
9.
12 p, 363.1 KB Renal Biopsy in Type 2 Diabetic Patients / Espinel, Eugenia (Hospital Universitari Vall d'Hebron) ; Agraz Pamplona, Irene (Hospital Universitari Vall d'Hebron) ; Ibernon, Meritxell (Hospital Universitari Vall d'Hebron) ; Ramos, Natalia (Hospital Universitari Vall d'Hebron) ; Fort, Joan (Hospital Universitari Vall d'Hebron) ; Serón, Daniel (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The majority of diabetic patients with renal involvement are not biopsied. Studies evaluating histological findings in renal biopsies performed in diabetic patients have shown that approximately one third of the cases will show pure diabetic nephropathy, one third a non-diabetic condition and another third will show diabetic nephropathy with a superimposed disease. [...]
2015 - 10.3390/jcm4050998
Journal of clinical medicine, Vol. 4 (may 2015) , p. 998-1009  
10.
9 p, 567.0 KB Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers : a randomized study / Espinel Garuz, Eugenia (Hospital Universitari Vall d'Hebron) ; Joven Maried, Jorge (Universitat Rovira i Virgili) ; Gil, Iván (Hospital Universitari Vall d'Hebron) ; Suñé, Pilar (Hospital Universitari Vall d'Hebron) ; Renedo, Berta (Hospital Universitari Vall d'Hebron) ; Fort Ros, Joan (Hospital Universitari Vall d'Hebron) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron)
Background: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are renoprotective but both may increase serum potassium concentrations in patients with chronic kidney disease (CKD). [...]
2013 - 10.1186/1756-0500-6-306
BMC public health, Vol. 6, N. 306 (August 2013) , p. 1-9  

Documentos de investigación Encontrados 4 registros  
1.
190 p, 4.7 MB Contribución de la inflamación del aloinjerto renal a la inflamación sistémica / Carabén Redaño, Anna ; Serón Micas, Daniel, dir. ; Fonollosa Pla, Vicent, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
El transplantament renal ha permès millorar la supervivència i la qualitat de vida dels pacients amb malaltia renal crònica ja que disminueix la mortalitat respecte als pacients en diàlisis. Malgrat això, la malaltia cardiovascular constitueix la primera causa de defunció del pacient després del trasplantament renal i està associada a la presència d'inflamació sistèmica (nivells elevats de proteïna C reactiva o de la interleucina 6 en sang). [...]
El trasplante renal ha permitido mejorar la supervivencia y la calidad de vida de los pacientes con enfermedad renal crónica ya que disminuye la mortalidad respecto a los pacientes en diálisis. A pesar de esto, la enfermedad cardiovascular constituye la primera causa de fallecimiento del paciente después del trasplante renal y está asociada a la presencia de inflamación sistémica (niveles elevados de proteína C reactiva o de la interleucina 6 en sangre). [...]
Renal transplantation has improved the survival and life quality of patients with chronic kidney disease since it reduces mortality compared to patients in dialysis. Despite this fact, cardiovascular disease is the first cause of death of kidney transplanted patients and is associated with the presence of systemic inflammation (elevated blood levels of C-reactive protein or interleukin 6). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2020.  
2.
102 p, 5.7 MB La inflamación subclínica del injerto como modulador de la evolución del trasplante renal : repercusión a nivel inmunológico, histológico y sistémico / García Carro, Clara ; Serón Micas, Daniel, dir. ; Moreso, Francesc, dir. ; Fonollosa Pla, Vicent, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
El trasplante renal es el tratamiento de elección de la ERC terminal. Enlas últimas décadas, ha mejorado de manera notable la supervivenciadel paciente y del injerto a corto y medio plazo. Sin embargo, a los 10años del trasplante, el 25-35% presenta disfunción del órgano,requiriendo tratamiento dialítico. [...]
Kidney transplantation is the treatment of choice for end-stage CKD. In the last decades, graft and patient survival have dramatically improved. However, at 10 years after transplantation, 25-35% of patients present graft failures and the necessity of renal replacement therapy. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2019.  
3.
285 p, 4.1 MB Estudio exploratorio observacional y prospectivo de la maduración de la fístula arteriovenosa (FAV) nativa : estudio "MAFAVI" / Gil Carballeira, Iván ; Serón Micas, Daniel, dir. ; Moreso, Francesc, dir. ; Vilardell, Miquel, 1946-, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
[Bellaterra] : Universitat Autònoma de Barcelona, 2017.  
4.
142 p, 1.7 MB Alteraciones de la inmunidad innata, inflamación de bajo grado y progresión de la aterosclerosis subclínica en pacientes con enfermedad renal crónica y en trasplantados renales / Azancot, María A. ; Serón Micas, Daniel, dir. ; Guardia Massó, Jaume, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Introducción: La enfermedad cardiovascular se presenta de forma muy precoz en los pacientes con enfermedad renal crónica (ERC) y trasplantados renales, siendo la principal causa de mortalidad en estas poblaciones. [...]
Introduction: Cardiovascular disease is prevalent in patients with chronic kidney disease (CKD) and kidney transplants and constitutes a main cause of death in these patients. The classical cardiovascular risk factors (i. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  

Vea también: autores con nombres similares
9 Seron, Daniel
1 Serón, D.R.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.